SPHK1

sphingosine kinase 1

Basic information

Region (hg38): 17:76376583-76387860

Links

ENSG00000176170NCBI:8877OMIM:603730HGNC:11240Uniprot:Q9NYA1AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SPHK1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SPHK1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
2
missense
21
clinvar
1
clinvar
1
clinvar
23
nonsense
0
start loss
0
frameshift
1
clinvar
1
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
0
Total 0 0 21 2 3

Variants in SPHK1

This is a list of pathogenic ClinVar variants found in the SPHK1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-76385160-G-A not specified Uncertain significance (Jan 19, 2024)3169015
17-76385481-C-A Likely benign (Aug 13, 2018)731910
17-76385481-C-T not specified Uncertain significance (Feb 05, 2024)3169018
17-76385531-T-G not specified Uncertain significance (Jan 24, 2024)3169014
17-76385986-G-C Benign (Jun 14, 2018)784746
17-76386008-C-T not specified Uncertain significance (Oct 06, 2021)2356726
17-76386117-C-T not specified Uncertain significance (Aug 08, 2022)2350999
17-76386226-C-G not specified Uncertain significance (Mar 21, 2023)2527819
17-76386430-C-G not specified Uncertain significance (May 28, 2024)3322185
17-76386444-C-G not specified Uncertain significance (Nov 08, 2022)2323848
17-76386445-C-T not specified Uncertain significance (Dec 20, 2023)3169016
17-76386810-G-A not specified Uncertain significance (Apr 20, 2023)2539701
17-76386897-C-T not specified Uncertain significance (Oct 22, 2021)2410704
17-76386899-C-T Benign (Feb 08, 2018)785584
17-76386915-C-A not specified Uncertain significance (Jun 01, 2023)2511867
17-76386984-C-T not specified Uncertain significance (Nov 19, 2022)2410043
17-76387020-T-C not specified Uncertain significance (Nov 07, 2022)2322527
17-76387026-CG-C Likely benign (Dec 31, 2019)789900
17-76387028-T-C Benign (Dec 31, 2019)789901
17-76387053-G-A not specified Uncertain significance (Apr 28, 2023)2519154
17-76387057-G-C not specified Uncertain significance (Dec 17, 2023)3169017
17-76387110-G-A not specified Uncertain significance (Jul 05, 2023)2609833
17-76387143-C-T not specified Uncertain significance (Jul 13, 2022)2301390
17-76387317-C-T not specified Uncertain significance (Oct 17, 2023)3169011
17-76387349-G-A not specified Uncertain significance (Apr 08, 2024)3322182

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SPHK1protein_codingprotein_codingENST00000323374 611277
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.03e-70.32812512226131257370.00245
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.4892793030.9210.00001842930
Missense in Polyphen4556.9790.78976551
Synonymous-1.241521341.140.000008351052
Loss of Function0.4911112.90.8526.33e-7150

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.002140.00212
Ashkenazi Jewish0.0009950.000993
East Asian0.00006060.0000544
Finnish0.001630.00162
European (Non-Finnish)0.003180.00317
Middle Eastern0.00006060.0000544
South Asian0.004250.00419
Other0.003270.00326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Catalyzes the phosphorylation of sphingosine to form sphingosine 1-phosphate (SPP), a lipid mediator with both intra- and extracellular functions. Also acts on D-erythro- sphingosine and to a lesser extent sphinganine, but not other lipids, such as D,L-threo-dihydrosphingosine, N,N- dimethylsphingosine, diacylglycerol, ceramide, or phosphatidylinositol. {ECO:0000269|PubMed:20577214, ECO:0000269|PubMed:23602659}.;
Pathway
Fc gamma R-mediated phagocytosis - Homo sapiens (human);VEGF signaling pathway - Homo sapiens (human);Calcium signaling pathway - Homo sapiens (human);Apelin signaling pathway - Homo sapiens (human);Tuberculosis - Homo sapiens (human);Sphingolipid signaling pathway - Homo sapiens (human);Phospholipase D signaling pathway - Homo sapiens (human);Sphingolipid metabolism - Homo sapiens (human);Sphingolipid Metabolism;Signal Transduction of S1P Receptor;Metabolism of Spingolipids in ER and Golgi apparatus;Signal Transduction;phospholipids as signalling intermediaries;VEGFA-VEGFR2 Pathway;Metabolism of lipids;Metabolism of proteins;Chaperonin-mediated protein folding;Metabolism;Association of TriC/CCT with target proteins during biosynthesis;Fibroblast growth factor-1;Glycosphingolipid metabolism;Beta3 integrin cell surface interactions;Protein folding;Signaling by VEGF;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;sphingosine and sphingosine-1-phosphate metabolism;Signaling by Receptor Tyrosine Kinases;Fc-epsilon receptor I signaling in mast cells;S1P1 pathway;PDGFR-beta signaling pathway;Sphingosine 1-phosphate (S1P) pathway;VEGFR2 mediated cell proliferation (Consensus)

Recessive Scores

pRec
0.236

Intolerance Scores

loftool
0.821
rvis_EVS
-0.22
rvis_percentile_EVS
37.54

Haploinsufficiency Scores

pHI
0.134
hipred
Y
hipred_score
0.505
ghis
0.521

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.999

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Sphk1
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; embryo phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; endocrine/exocrine gland phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype;

Zebrafish Information Network

Gene name
sphk1
Affected structure
heart
Phenotype tag
abnormal
Phenotype quality
split bilaterally

Gene ontology

Biological process
blood vessel development;sphingosine-1-phosphate receptor signaling pathway;protein folding;sphingosine metabolic process;inflammatory response;signal transduction;brain development;positive regulation of peptidyl-threonine phosphorylation;regulation of tumor necrosis factor-mediated signaling pathway;calcium-mediated signaling;sphingolipid biosynthetic process;positive regulation of cell growth;positive regulation of cell migration;positive regulation of protein ubiquitination;regulation of interleukin-1 beta production;intracellular signal transduction;negative regulation of apoptotic process;positive regulation of angiogenesis;positive regulation of mitotic cell cycle;positive regulation of smooth muscle contraction;sphingosine biosynthetic process;sphingoid catabolic process;lipid phosphorylation;positive regulation of fibroblast proliferation;positive regulation of NF-kappaB transcription factor activity;positive regulation of NIK/NF-kappaB signaling
Cellular component
nucleus;cytoplasm;cytosol;plasma membrane
Molecular function
magnesium ion binding;DNA binding;NAD+ kinase activity;protein binding;calmodulin binding;ATP binding;sphinganine kinase activity;D-erythro-sphingosine kinase activity;sphingosine-1-phosphate receptor activity;protein phosphatase 2A binding